NERVECTOBAR

Nervectobar is a clinically formulated neurological support supplement designed to address the root causes and symptoms of peripheral neuropathy — with a primary focus on diabetic neuropathy. Unlike general B-vitamin supplements, Nervectobar is built around evidence-based therapeutic concentrations validated by European clinical trials.

 

The formula combines two powerful neuroprotective anchors — Alpha-Lipoic Acid and Benfotiamine — with the most bioavailable and neurologically active forms of key B vitamins, plus Vitamin D3 for immune and inflammatory nerve support. Together, these five components create a synergistic protocol targeting nerve pain, progressive nerve damage, and long-term nerve regeneration.

 

Ingredient	Dose	Therapeutic Feature	Clinical Benefit
Alpha-Lipoic Acid (ALA)	600 mg	WHO/European Therapeutic Dose	Reduces nerve pain and tingling; improves nerve conduction velocity; powerful antioxidant protecting nerve tissue from oxidative damage
Benfotiamine (Vitamin B1)	150 mg	Fat-Soluble B1 — High Bioavailability	Blocks AGE formation that damages nerves in diabetes; superior absorption vs. standard thiamine; reduces neuropathic progression
Pyridoxine HCl (Vitamin B6)	25 mg	Optimal Safe Neurological Dose	Supports synthesis of GABA, Dopamine & Serotonin; reduces tingling and nerve pain; safe long-term dose (avoids neurotoxicity risk above 50 mg/day)
Methylcobalamin (Vitamin B12)	1000 mcg	Active Form — Therapeutic Protocol Dose	Promotes nerve regeneration (Schwann cell support); reduces numbness and weakness; superior to Cyanocobalamin for neurological outcomes
Cholecalciferol (Vitamin D3)	1000 IU	Preventive & Supportive Neurological Dose	Reduces neuroinflammation; corrects common deficiency in neuropathy patients; supports immune nerve protection

 

Patient Group	Recommended Dose	Notes
Diabetic neuropathy	1 capsule daily	With meal; consistent use for minimum 3 months
Vitamin B12 deficiency neuropathy	1 capsule daily	Monitor B12 serum levels at 3 months
Chemotherapy-induced neuropathy	1 capsule daily	Under oncologist guidance
Neuralgia / chronic nerve pain	1 capsule daily	Combine with analgesic protocol if needed
Preventive neuroprotection (metabolic syndrome)	1 capsule daily	Long-term maintenance use is safe

•       Do not exceed recommended daily dose without physician supervision.

•       Alpha-Lipoic Acid may lower blood glucose — diabetic patients on insulin or oral hypoglycemics should monitor blood sugar levels, especially at initiation.

•       Vitamin B6 at doses above 50 mg/day over prolonged periods may cause peripheral neuropathy — Nervectobar's 25 mg dose is well within the safe long-term range.

•       Not a substitute for prescribed diabetic neuropathy medications — intended as adjunctive therapeutic support.

•       Store in a cool, dry place away from direct sunlight and moisture.

•       Keep out of reach of children.

 

Warning: This product is not intended to diagnose, treat, cure, or

prevent any disease and not considered as a replacement

for a balanced nutritional diet or for a healthy life style.